The $170 million acquisition brings Origin’s AI sensing technology and more than 200 patents into ADT’s platform, with commercialization of new offerings expected in 2027.

Immunotherapy has been generally ineffective for prostate cancer because the tumors are considered immunologically "cold," meaning they do not attract enough immune cells to mount a strong attack.

Discover the top 4 undervalued Diversified Consumer Services stocks for Wednesday, February 25 based on AAII’s Stock Grades.

To celebrate 250 years of America, the American Discovery Trail Society (ADTS) is hosting a coast-to-coast relay on the American Discovery Trail (ADT), scheduled to start on July 4 and ...

More Australians are turning to technology to better understand their everyday habits – and driving is no exception.

Average daily turnover (ADT) in the cash segment rose to Rs 1.2 lakh crore, up 27% month-on-month (MoM) and 24% year-on-year (YoY).

A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with ...

Check your weather forecast for clear skies, so you don't miss the spectacular astronomical events occurring throughout the ...

Bayer's Nubeqa gains approval in India for non-chemotherapy treatment of advanced prostate cancer, enhancing patient care ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Friday, February 20 based on AAII’s Stock Grades.

Rahul Parikh, MD, a professor of medicine at the University of Kansas (KU) Medical Center, discussed the critical role of ...

Bayer expands Nubeqa in India as a treatment option without chemotherapy for men with metastatic hormone sensitive prostate cancer: Our Bureau, Bengaluru Tuesday, February 24, 202 ...